NASDAQ:PSTV

Plus Therapeutics Stock Predictions

etoro logo Buy PSTV
*Your capital is at risk
$5.42
-0.0500 (-0.91%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

PSTV Prediction Chart

PSTV Predictions History

Latest community submissions for PSTV.
Predictor Target Session Target Price Result Direction Accuracy Score
Aug 8, 2025 $0.734 -96.13% $0.795 V 92.33% 0
ir1998ri ir1998ri Amateur
Aug 8, 2025 Bearish $0.795 V 0
Aug 8, 2025 Bullish $0.795 X 1
Aug 8, 2025 Bullish $0.795 X 1
Aug 7, 2025 Bullish $0.759 X 0
Aug 7, 2025 $0.719 -96.21% $0.759 V 94.77% 1
Aug 7, 2025 $0.734 -96.13% $0.759 V 96.78% 1
ir1998ri ir1998ri Amateur
Aug 7, 2025 Bearish $0.759 V 1
Aug 6, 2025 $0.619 -96.24% $0.760 V 81.43% 0
Aug 6, 2025 $0.633 -96.15% $0.760 V 83.37% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for PSTV with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT PLUS THERAPEUTICS, INC.
Plus Therapeutics
Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer and other diseases. Its lead drug candidate is Rhenium-186 NanoLiposome, a patented radiotherapy that targets central nervous system cancers, including recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancers. It has a license agreement with NanoTx, Corp. to d...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE